These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 2337964)

  • 1. Stability prediction of nafamostat mesilate in an intravenous admixture containing sodium bisulfite.
    Asahara K; Yamada H; Yoshida S; Hirose S
    Chem Pharm Bull (Tokyo); 1990 Feb; 38(2):492-7. PubMed ID: 2337964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of the stability of octreotide in a mixed infusion.
    Takasu Y; Yoshida M; Shimizu K; Asahara K; Tange M; Uchida T
    Chem Pharm Bull (Tokyo); 2014; 62(4):316-21. PubMed ID: 24695340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction of the stability of meropenem in intravenous mixtures.
    Takasu Y; Yoshida M; Tange M; Asahara K; Uchida T
    Chem Pharm Bull (Tokyo); 2015; 63(4):248-54. PubMed ID: 25832020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of the stability of imipenem in intravenous mixtures.
    Yoshida M; Takasu Y; Shimizu K; Asahara K; Uchida T
    Chem Pharm Bull (Tokyo); 2013; 61(1):1-7. PubMed ID: 23124620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stability of human insulin in solutions containing sodium bisulfite.
    Asahara K; Yamada H; Yoshida S
    Chem Pharm Bull (Tokyo); 1991 Oct; 39(10):2662-6. PubMed ID: 1806287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thiamine destruction by sodium bisulfite in infusion solutions.
    Scheiner JM; Araujo MM; DeRitter E
    Am J Hosp Pharm; 1981 Dec; 38(12):1911-3. PubMed ID: 7325171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Compatibility of carbapenem antibiotics with nafamostat mesilate in arterial infusion therapy for severe acute pancreatitis: stabilities of carbapenem antibiotics.
    Hamada Y; Imaizumi H; Miyazawa S; Kida M; Souma K; Koizumi W; Sunakawa K; Kuroyama M
    Jpn J Antibiot; 2012 Aug; 65(4):235-49. PubMed ID: 23259254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is high-dose nafamostat mesilate effective for the prevention of post-ERCP pancreatitis, especially in high-risk patients?
    Park KT; Kang DH; Choi CW; Cho M; Park SB; Kim HW; Kim DU; Chung CW; Yoon KT
    Pancreas; 2011 Nov; 40(8):1215-9. PubMed ID: 21775918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stability and compatibility of doxofylline with phentolamine mesilate in 0.9% sodium chloride or 5% dextrose injection for intravenous infusion.
    Xu F; Xu G; Su L; Feng E
    J Clin Pharm Ther; 2011 Feb; 36(1):99-102. PubMed ID: 21198724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A method for quantifying the unstable and highly polar drug nafamostat mesilate in human plasma with optimized solid-phase extraction and ESI-MS detection: more accurate evaluation for pharmacokinetic study.
    Cao YG; Zhang M; Yu D; Shao JP; Chen YC; Liu XQ
    Anal Bioanal Chem; 2008 Jun; 391(3):1063-71. PubMed ID: 18392693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stability of urokinase in solutions containing sodium bisulfite.
    Asahara K; Yamada H; Yoshida S; Hirose S
    Chem Pharm Bull (Tokyo); 1990 Jun; 38(6):1675-9. PubMed ID: 2208381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Randomized Comparative Study of 24- and 6-Hour Infusion of Nafamostat Mesilate for the Prevention of Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis: A Prospective Randomized Comparison Trial.
    Kim SJ; Kang DH; Kim HW; Choi CW; Park SB; Song BJ; Nam HS
    Pancreas; 2016 Sep; 45(8):1179-83. PubMed ID: 27253231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of nafamostat mesilate as an inhibitor of the fat mass and obesity-associated protein (FTO) demethylase activity.
    Han X; Wang N; Li J; Wang Y; Wang R; Chang J
    Chem Biol Interact; 2019 Jan; 297():80-84. PubMed ID: 30393114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beneficial effect of therapeutic infusion of nafamostat mesilate (FUT-175) on hemodynamics in experimental acute pancreatitis.
    Dobosz M; Sledzinski Z; Juszkiewicz P; Babicki A; Stanek A; Wajda Z; Basinski A
    Hepatogastroenterology; 1991 Apr; 38(2):139-42. PubMed ID: 1855771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adsorption of Nafamostat Mesilate on AN69ST Membranes: A Single-Center Retrospective and In Vitro Study.
    Nakamura Y; Hara S; Hatomoto H; Yamasaki S; Nakano T; Miyazaki M; Matsumoto N; Irie Y; Ishikura H
    Ther Apher Dial; 2017 Dec; 21(6):620-627. PubMed ID: 28960755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and Tolerability of Nafamostat Mesilate and Heparin as Anticoagulants in Leukocytapheresis for Ulcerative Colitis: Post Hoc Analysis of a Large-Scale, Prospective, Observational Study.
    Sawada K; Ohdo M; Ino T; Nakamura T; Numata T; Shibata H; Sakou J; Kusada M; Hibi T
    Ther Apher Dial; 2016 Apr; 20(2):197-204. PubMed ID: 26771066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Studies on the formulation and admixture of parenteral preparations. II. Degradation of penicillins and cephalospolin C's by sodium bisulfite].
    Terao M; Marui E; Yonezawa S; Kawashima N
    Yakugaku Zasshi; 1982 Oct; 102(10):978-83. PubMed ID: 7166733
    [No Abstract]   [Full Text] [Related]  

  • 18. Differences in the adsorption of nafamostat mesilate between polyester-polymer alloy and polysulfone membranes.
    Goto S; Ookawara S; Saito A
    J Artif Organs; 2017 Jun; 20(2):138-144. PubMed ID: 27896500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nafamostat mesilate, a kallikrein inhibitor, prevents pain on injection with propofol.
    Iwama H; Nakane M; Ohmori S; Kaneko T; Kato M; Watanabe K; Okuaki A
    Br J Anaesth; 1998 Dec; 81(6):963-4. PubMed ID: 10211027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cimetidine hydrochloride compatibility. II: room temperature stability in intravenous infusion fluids.
    Yuhas EM; Lofton FT; Mayron D; Baldinus JG; rosenberg HA
    Am J Hosp Pharm; 1981 Jun; 38(6):879-81. PubMed ID: 7246564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.